Inactive Instrument

Press Releases Albany Molecular Research, Inc.

Equities

US0124231095

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	18-01-17	PU
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	18-01-04	PU
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	17-12-19	PU
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	17-11-30	PU
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	17-11-09	PU
Albany Molecular Research : AMRI to Exhibit and Present at MD&M Minneapolis 2017	17-11-02	PU
Albany Molecular Research : AMRI Appoints Paul Feuerman as Senior Vice President General Counsel and Head of Busine...	17-10-31	PU
Robbins Geller Rudman & Dowd LLP : Files Class Action Suit against Albany Molecular Research, Inc.	17-10-25	BU
Albany Molecular Research : AMRI to Highlight Sterile Manufacturing Capacity Expansion, New Technologies at CPhI	17-10-23	PU
Albany Molecular Research : AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis and Toxico...	17-10-12	PU
Albany Molecular Research : AMRI Names Joseph D. Sangregorio as Senior Vice President and Chief Human Resources Off...	17-10-02	PU
Albany Molecular Research : AMRI Assembles a Comprehensive Medical Device Expert Solutions Team	17-09-21	PU
Albany Molecular Research : AMRI’s John Iannone Named US Expert to ISO Technical Committee	17-09-13	PU
3ST Research : Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)	17-09-12	PR
Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information	17-06-13	BU
WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders	17-06-09	PR
Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information	17-06-07	BU
Albany Molecular Research : Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research	17-06-07	PR
ALBANY MOLECULAR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albany Molecular Research, Inc.	17-06-06	PR
AMRI : Announces First Quarter 2017 Results	17-05-09	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Albany Molecular Research, Inc.

Equities

US0124231095

Press Releases

Filters